Plasmodium falciparum Guanylyl Cyclase-Alpha and the Activity of Its Appended P4-ATPase Domain Are Essential for cGMP Synthesis and Blood-Stage Egress. by Nofal, Stephanie D et al.
Plasmodium falciparum Guanylyl Cyclase-Alpha and the Activity
of Its Appended P4-ATPase Domain Are Essential for cGMP
Synthesis and Blood-Stage Egress
Stephanie D. Nofal,a* Avnish Patel,a Michael J. Blackman,a,b Christian Flueck,a David A. Bakera
aFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
bMalaria Biochemistry Laboratory, The Francis Crick Institute, London, United Kingdom
ABSTRACT Guanylyl cyclases (GCs) synthesize cyclic GMP (cGMP) and, together
with cyclic nucleotide phosphodiesterases, are responsible for regulating levels of
this intracellular messenger which mediates myriad functions across eukaryotes. In
malaria parasites (Plasmodium spp), as well as their apicomplexan and ciliate rela-
tives, GCs are associated with a P4-ATPase-like domain in a unique bifunctional con-
figuration. P4-ATPases generate membrane bilayer lipid asymmetry by translocating
phospholipids from the outer to the inner leaflet. Here, we investigate the role of
Plasmodium falciparum guanylyl cyclase alpha (GCa) and its associated P4-ATPase
module, showing that asexual blood-stage parasites lacking both the cyclase and
P4-ATPase domains are unable to egress from host erythrocytes. GCa-null parasites
cannot synthesize cGMP or mobilize calcium, a cGMP-dependent protein kinase
(PKG)-driven requirement for egress. Using chemical complementation with a cGMP
analogue and point mutagenesis of a crucial conserved residue within the P4-
ATPase domain, we show that P4-ATPase activity is upstream of and linked to cGMP
synthesis. Collectively, our results demonstrate that GCa is a critical regulator of PKG
and that its associated P4-ATPase domain plays a primary role in generating cGMP
for merozoite egress.
IMPORTANCE The clinical manifestations of malaria arise due to successive rounds of
replication of Plasmodium parasites within red blood cells. Once mature, daughter
merozoites are released from infected erythrocytes to invade new cells in a tightly
regulated process termed egress. Previous studies have shown that the activation of
cyclic GMP (cGMP) signaling is critical for initiating egress. Here, we demonstrate
that GCa, a unique bifunctional enzyme, is the sole enzyme responsible for cGMP
production during the asexual blood stages of Plasmodium falciparum and is
required for the cellular events leading up to merozoite egress. We further demon-
strate that in addition to the GC domain, the appended ATPase-like domain of GCa
is also involved in cGMP production. Our results highlight the critical role of GCa in
cGMP signaling required for orchestrating malaria parasite egress.
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Signaling through 39,59-cyclic GMP (cyclic GMP [cGMP]) regulates innumerable cellu-lar processes across the animal kingdom, ranging from the control of cardiovascu-
lar function (reviewed in reference 1) and phototransduction (reviewed in reference 2)
in mammals to differentiation and locomotion in several unicellular organisms (reviewed
in reference 3). Two central players in the cGMP pathway are guanylyl cyclases (GCs),
which synthesize cGMP from GTP, and phosphodiesterases (PDEs), which degrade cGMP.
Cellular levels of cGMP are tightly regulated by the opposing action of these two enzyme
classes. Upon reaching threshold levels, cGMP activates downstream effectors such as
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the cGMP-dependent protein kinase (PKG) or cGMP-gated ion channels. In the protozoan
parasites responsible for malaria (Plasmodium spp.), PKG is thought to be the only direct
effector of cGMP signaling since canonical cGMP-gated ion channels are absent from the
genome (4). Malaria parasites have two GC paralogues which are structurally distinct
from both types of mammalian GC (5–7). Each Plasmodium GC possesses a C-terminal
domain with an overall topology similar to G protein-dependent adenylyl cyclases, com-
prising two catalytic domains each preceded by a set of six transmembrane helices.
These twin catalytic domains contain all of the conserved amino acid residues required
for cGMP synthesis. However, while mammalian G protein-dependent adenylyl cyclases
are activated following binding of heterotrimeric G proteins once a ligand binds to a G
protein-coupled receptor, G proteins are absent from the Plasmodium genome, suggest-
ing an alternate mechanism of activation. In addition to the cyclase domain, Plasmodium
GCs also possess an N-terminal domain that has high structural similarity to P4-ATPases
or flippases (5, 8). In other organisms, flippases translocate phospholipids from the
outer/luminal to the cytosolic leaflet of a membrane lipid bilayer, creating membrane
asymmetry important for membrane remodeling, vesicular transport and signaling
(reviewed in references 9–11). Most phospholipid flippases function in partnership with
an integral membrane Cell Division Control protein 50 (CDC50), which acts as a chaper-
one for the enzyme and is required for flippase activity (12, 13). The physical linkage of a
guanylyl cyclase with a P4-ATPase domain is unique to Plasmodium and its apicom-
plexan and ciliate relatives (5, 8, 14–17). Recent work in Toxoplasma gondii has investi-
gated the role of the single GC isoform in parasite development. The Toxoplasma GC
(TgGC) localizes to the plasma membrane at the basal and apical ends of invasive tachy-
zoites (15–18). Conditional knockdown of TgGC revealed that it is responsible for cGMP
production, which is required for parasite egress, calcium release, microneme exocytosis,
motility, host cell attachment, and invasion (15–18). TgGC requires interaction with a
CDC50 protein and a unique GC organizer, which act as chaperones for the ATPase and
GC domains, respectively (14). The ATPase domain is required for targeting TgGC to the
apical end of the parasite (15) and mutagenesis of key residues required for ATPase activ-
ity inhibit microneme release and lytic growth (14, 15). GC-mediated phospholipid flip-
ping activity could not be detected (14); however, there is evidence that TgGC is
involved in sensing extracellular pH and K1 levels (17), as well as phosphatidic acid (PA)
(14).
The complex life cycle of the malaria parasite is divided between a vertebrate host
and a mosquito vector, and there is abundant evidence that cGMP signaling is crucial
for parasite survival across multiple developmental stages. While the asexual blood
stages are solely responsible for clinical disease in the vertebrate host, a crucial step for
transmission to the vector is the generation of sexual gametocyte forms. Upon uptake
in a blood meal, the gametocytes are activated by a combination of reduced tempera-
ture with either an increase in pH or the presence of the mosquito factor xanthurenic
acid (XA) (19), triggering the emergence of male and female gametes (gametogenesis).
An early study using pharmacological agents suggested a role for cGMP signaling in
male gamete activation in the mosquito (61), and the action of XA was subsequently
linked to elevated cGMP levels in vitro (20). Using chemical genetic approaches, we
showed that cGMP signaling through PKG is essential for gametogenesis (21) and also
for gliding motility of ookinetes (22), motile forms that develop from the zygote that
results from gamete fertilization. Of the two P. falciparum GC isoforms, GCb is dispen-
sable for blood-stage development and is expressed exclusively in the mosquito stages
(23), where it is required for cGMP synthesis to drive and maintain P. berghei ookinete
gliding motility (22, 24, 25). GCb becomes polarized during ookinete formation, is sta-
bilized by a CDC50 protein, and is thought to elevate local levels of cGMP to facilitate
gliding motility (8). The ookinetes penetrate the mosquito midgut epithelium and form
oocysts in which thousands of sporozoites form; these then migrate to and invade the
mosquito salivary glands. Dysregulation of cGMP levels by deletion of phosphodiester-
ase-gamma (PDEg) in the rodent malaria species Plasmodium yoelii blocks salivary gland
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invasion and subsequent parasite development (26). In another rodent malaria parasite,
P. berghei, PKG is required for sporozoite motility and invasion of hepatocytes following
injection of sporozoites into a host by the mosquito (27). Furthermore, conditional dis-
ruption of PKG reduces the release of merosomes containing merozoites into the blood-
stream prior to erythrocyte invasion (28).
In contrast to GCb , transcriptomic data indicate that P. falciparum GCa is expressed
in both gametocytes and the asexual blood stages of the life cycle (https://plasmodb
.org/plasmo/). The GCa gene has so far proved refractory to disruption in asexual blood
stages (23, 25, 29), consistent with an important role during this clinically relevant
stage. Confirmation of a key role for cGMP signaling in blood stages was obtained
using a chemical genetic approach which demonstrated that PKG is essential for schiz-
ont rupture (30). This observation was subsequently extended to show that just prior
to merozoite egress, PKG regulates the discharge of the subtilisin-like protease SUB1
from organelles termed exonemes into the parasitophorous vacuole (PV) of mature P.
falciparum schizonts, where it proteolytically processes a number of proteins required
for merozoite egress and invasion (31, 32). PKG activity is also required for the release
of calcium ions (Ca21) from internal stores that is a prerequisite for egress (22). In
efforts to dissect the mechanistic basis of this PKG-dependent egress pathway, com-
parative phosphoproteomic analysis identified 69 proteins that are phosphorylated in
a cGMP-dependent manner (33). Very recently, the essential role for PKG in egress was
confirmed through conditional genetic approaches (34). Despite this clear evidence for
a crucial role for PKG in the asexual blood-stage life cycle, the role of GCa and its
appended P4-ATPase domain remains unexplored.
Here, we show that GCa is essential for P. falciparum blood-stage egress and that
GCa-null parasites cannot synthesize cGMP or mobilize Ca21. Crucially, we show that
activity of the P4-ATPase domain of GCa is essential and that it functions upstream of
cGMP synthesis.
RESULTS
P. falciparum GCa is expressed during late asexual blood-stage development
and localizes to cytoplasmic vesicular structures in newly formed merozoites.
Upon invasion of a red blood cell by a malaria merozoite, the parasite transforms
through ring and trophozoite stages and then undergoes DNA replication to form a
multinucleated schizont that eventually segments to form a new generation of daugh-
ter merozoites. These are then released upon egress to invade fresh red cells and
repeat the cycle. Invasion is driven by an actinomyosin-based contractile complex of-
ten referred to as the glideosome, which lies beneath the pellicular membrane of the
merozoite. Data from several previous transcriptome studies show that GCa mRNA
expression peaks at the schizont stage, while proteomic analysis indicates presence of
the protein in schizonts and merozoites (http://plasmodb.org/). To define the timing of
expression of GCa at the protein level and to determine its subcellular localization, we
generated a P. falciparum line expressing GCa fused to a C-terminal triple hemaggluti-
nin (3HA) epitope tag. For this, we used the P. falciparum 1G5 clone, which constitu-
tively expresses a dimerizable Cre recombinase (DiCre) that can be activated by
treatment with rapamycin (RAP) (35). The tagging strategy used single crossover ho-
mologous recombination at the 39 end of the endogenous GCa gene, along with intro-
duction of a human dihydrofolate reductase (hDHFR) selection cassette flanked by two
loxP sites (Fig. 1A). Initial selection for transformants with the antifolate WR99210, fol-
lowed by several rounds of drug cycling, enriched for parasites in which integration
had occurred. The hDHFR selectable marker was then recycled by RAP-induced Cre
recombinase-mediated excision of the floxed sequence, leaving behind a single loxP
site immediately downstream of the 3HA epitope tag and translational stop codon
(Fig. 1A). Two parasite clones were obtained that showed sensitivity to WR99210, sug-
gesting the expected genomic rearrangement with loss of the hDHFR selection marker
(Fig. 1B). The absence of the hDHFR cassette was confirmed in GCa:HA clone 1 by PCR
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FIG 1 Generation of a GCa:HA-tagged line and spatiotemporal expression of GCa in P. falciparum blood stages. (A) Schematic representation of the
single homology crossover approach used to fuse the 39 end of the endogenous GCa gene to a 3HA tag, and subsequent RAP-mediated excision of
(Continued on next page)
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analysis (Fig. 1C), and this transgenic parasite clone (referred to as GCa:HA) was subse-
quently used in all further experiments.
Tightly synchronized cultures of the GCa:HA line were sampled at 4-h intervals
from the early trophozoite stage (24 h postinvasion) to the mature schizont stage (48 h
postinvasion) and analyzed by Western blotting using a-HA antibodies. This revealed a
single specific signal migrating at ;175 kDa that was most intense in mature schizonts
(Fig. 1D). This molecular mass is consistent with a C-terminal GCa-3HA fragment pre-
dicted to comprise both the guanylyl cyclase catalytic domains (C1 and C2) plus the 12
associated transmembrane helices (Fig. 1E). No signal was detectable at the ;500-kDa
mass expected for the full-length protein.
To confirm the timing of GCa expression at the single cell level and to reveal its
subcellular localization, we performed dual staining immunofluorescence microscopy
(IFA) with anti-HA in combination with known markers for different subcellular com-
partments. In mature GCa:HA schizonts GCa localized to intracellular foci, but not the
plasma membrane as established by costaining with a merozoite surface protein 1
(MSP1) antibody (Fig. 1F, top panel). To further characterize the nature of the intracel-
lular compartment occupied by GCa, we costained with antibodies that react with api-
cal membrane antigen 1 (AMA1), a micronemal marker, or plasmepsin V, an endoplas-
mic reticulum-resident protein. The a-HA staining showed no significant overlap with
either of these markers, nor with a nuclear stain (Fig. 1F, middle and bottom panels).
We conclude that GCa localizes to non-apical, cytoplasmic vesicular structures and is
maximally expressed in mature schizonts.
GCa is essential for asexual blood-stage growth and merozoite egress. To inves-
tigate the function and essentiality of GCa, we used the DiCre recombinase system
(35) to inducibly disrupt the GCa gene. For this, we created a GCa conditional knock-
out (cKO) line by introducing a second loxP site into the GCa locus of the GCa:HA line.
This additional loxP site was incorporated within an artificial SERA2 intron (loxPint) (36)
inserted into the ATPase domain of GCa using marker-free CRISPR/Cas9-mediated
gene editing (see Fig. S1A in the supplemental material). Integration of the loxPint into
the GCa coding region was confirmed by PCR in the uncloned parasite population (see
Fig. S1B) and, following limiting-dilution cloning, two clones were obtained with the
desired modification (see Fig. S1C). One of these clones, called GCa:HA:cKO, was used
in all further experiments.
Activation of Cre recombinase in the GCa:HA:cKO line by the addition of RAP was
expected to excise DNA sequences encoding part of the ATPase domain and the entire
cyclase domain of GCa, abrogating both enzymatic activities (Fig. 2A). To examine the
efficiency of excision, synchronous cultures of young ring-stage parasites were treated
with either 50 nM RAP or the equivalent concentration of vehicle only (dimethyl sulfox-
ide [DMSO]) for 2 h and allowed to mature to the schizont stage. PCR analysis showed
highly efficient RAP-induced excision (Fig. 2B), while Western blot analysis showed
FIG 1 Legend (Continued)
the hDHFR cassette. Promoters/59 untranslated regions (UTRs) are indicated by arrows, and 39 UTRs/terminators are indicated by lollipops. Triangles
represent loxP sites; arrows with numbers represent the relative position of oligonucleotide primers used for diagnostic PCR. rGCa refers to
recodonized GCa gene sequences. (B) Growth curve for two cloned GCa:HA lines sensitive to treatment with 2.5 nM WR99210, consistent with
successful excision of the hDHFR cassette. The data presented are from counting parasites on Giemsa-stained blood smears. At least 100 parasites
were counted per condition. Clone 1 was used for all further experiments. (C) Diagnostic PCR analysis confirming successful integration of the 3HA
tag and efficient excision of the floxed hDHFR cassette in GCa:HA clone 1. Lane 1, parental 1G5DC; lane 2, GCa:HA nonexcised; lane 3, GCa:HA clone
1 (excised). (D) Western blot showing a time course of GCa:HA expression in P. falciparum blood stages. Parasites were harvested from cultures
synchronized to a 2-h invasion window at the times indicated, with representative microscopy images shown above each sample (hpi, hours
postinvasion). Scale bar, 5mm. Blots were probed with a monoclonal a-HA antibody to visualize the GCa:HA fusion protein and an anti-PKG antibody
as a staging control. GCa:HA migrated as an ;175-kDa fragment, while full-length protein (predicted ;499 kDa) could not be detected. Note that the
additional band at ;125 kDa (*) arises from a cross-reactivity of the a-HA antibody with an unrelated parasite protein, since it is also detected in
extracts from the unmodified 1G5 parental P. falciparum line (right panel). (E) Schematic representation of the domain architecture of GCa, showing
the N-terminal ATPase domain and the C-terminal guanylyl cyclase domain. The horizontal line with corresponding molecular mass shows the features
likely contained in the C-terminal GCa-HA fragment detected by Western blotting. (F) Dual staining IFA analysis of mature GCa:HA schizonts.
Formaldehyde-fixed thin films were stained with a-HA (green) and costained with antibodies to markers for known subcellular compartments (red):
MSP1 (parasite plasma membrane, top panel), AMA1 (micronemes, middle panel), and plasmepsin V (endoplasmic reticulum, bottom panel). Scale bar,
5mm. For additional images, see Fig. S2A in the supplemental material.
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FIG 2 Efficient conditional disruption of GCa results in a complete egress block. (A) Schematic representation of RAP-induced excision of a
portion of the ATPase domain and the entire GC domain of GCa in GCa:HA:cKO. Arrows represent the relative position of oligonucleotide
primers used for diagnostic PCR screens. (B) Diagnostic PCR analysis of DMSO- and RAP-treated GCa:HA:cKO parasites showing efficient
excision of the GCa gene following RAP treatment. A DNA control PCR was included, which amplified a small segment at an independent
locus (Pf3D7_1342600) to confirm the quality of the DNA used. The specific PCR primers used are indicated on the right, and their binding
sites are shown in panel A. (C) Western blot analysis of DMSO- and RAP-treated GCa:HA:cKO schizont lysates probed with an a-HA antibody,
showing loss of the ;175-kDa band in the RAP-treated sample, while the nonspecific ;125-kDa (*) band can still be observed in both
(Continued on next page)
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complete loss of the 175-kDa GCa-3HA signal in the RAP-treated GCa:HA:cKO schiz-
onts, confirming efficient gene disruption (Fig. 2C). In addition, immunofluorescence
microscopy showed loss of GCa-3HA at the single cell level (Fig. 2D; see also Fig. S2B
and C).
To assess the impact of GCa disruption on parasite viability and growth, we used
flow cytometry to assess the replication of DMSO-treated (control) and RAP-treated
GCa:HA:cKO parasites over three erythrocytic growth cycles. This revealed a complete
growth arrest resulting from disruption of the GCa locus (Fig. 2E). Examination of
Giemsa-stained GCa:HA:cKO parasites in the cycle of gene excision (cycle 0) revealed
that RAP-treated cultures developed normally and were able to form mature seg-
mented schizonts with a DNA content indistinguishable from control schizonts
(Fig. 2F). However, upon further incubation we observed an accumulation of schizonts
and a complete absence of newly formed ring-stage parasites, indicating that GCa is
required for egress (Fig. 2G). To further characterize and quantify the egress defect in
the GCa-null parasites, highly synchronized mature cycle 0 schizonts from DMSO- and
RAP-treated cultures were monitored by live time-lapse microscopy. This confirmed
that GCa-null parasites were unable to egress (Fig. 2H). Close examination of individual
frames of the time-lapse video series revealed no signs of swelling or PVM rupture in
GCa-null schizonts (Fig. 2I). Consistent with the above results, the abundant PV-resi-
dent protein SERA5, which is released during egress, was not detectable in culture su-
pernatant samples from RAP-treated cultures (Fig. 2J). Collectively, these results estab-
lish that GCa plays an essential role in the asexual blood-stage life cycle and is
required for merozoite egress.
GCa is responsible for cGMP production and essential for calcium release in
asexual blood-stage schizonts. The phenotypic similarity between the egress block
observed in GCa-null schizonts and that produced by the PKG inhibitor compound 2
(Fig. 2I and Fig. 3A) is consistent with GCa-null schizonts failing to activate PKG due to
a lack of cGMP synthesis. To evaluate the impact of GCa disruption on cyclic nucleotide
production, we compared intracellular cGMP concentrations in mature cycle 0 GCa:HA:
cKO schizonts from DMSO- or RAP-treated cultures. For these experiments, in order to
prevent egress of the DMSO-treated (control) schizonts, both sets of parasites under
comparison were maintained in the presence of compound 2. This analysis showed
that ablation of GCa led to a 94.5% reduction in cGMP levels compared to control par-
asites (Fig. 3B). Treatment with the PDE inhibitor zaprinast, which blocks cGMP hydroly-
FIG 2 Legend (Continued)
samples. The blots were also probed with an a-PKG antibody to serve as a loading control. (D) Parallel IFA analysis of mature schizonts from
DMSO- and RAP-treated GCa:HA:cKO cultures shows loss of GCa-3xHA protein at the single cell level. Formaldehyde-fixed thin films were
probed with a-HA (green) and a-AMA1 (red) antibodies. Scale bar, 5mm. This analysis also confirms the specificity of the signal obtained
with anti-HA. Additional images are shown in Fig. S2B and C. (E) Growth curves showing parasitemia of GCa:HA:cKO cultures treated with
either DMSO or RAP, measured over three replication cycles by flow cytometry-based counting of SYBR green-positive cells. Data points
plotted are means from two repeat experiments, each performed in triplicate. Error bars indicate the standard deviations. Note that from
;16 days after RAP treatment parasites emerged, but these were evidently not GCa-null since PCR showed that the GCa locus was intact
(see Fig. S3A and B). (F) Comparison of the DNA content in wild-type and GCa-null schizonts. Schizonts obtained from synchronous DMSO-
and RAP-treated GCa:HA:cKO cultures were arrested using compound 2 to prevent egress and fixed at ;46 h postinvasion, and parasite DNA
was stained with SYBR green. SYBR green fluorescence intensity was measured by FACS counting from technical triplicates. (G)
Representative microscopy images of Giemsa-stained parasites from DMSO- and RAP-treated GCa:HA:cKO cultures at ;50 h postinvasion,
showing the accumulation of schizonts in the RAP-treated culture while new ring-stage parasites formed in the DMSO control culture. Scale
bar, 5mm. (H) Combined DIC and fluorescence images from time-lapse video microscopy of DMSO- and RAP-treated GCa:HA:cKO schizonts
taken at 5 min (T=5) and 30 min (T= 30) after release from a compound 2 block applied to transiently prevent and subsequently
synchronize egress. In each experiment, one subset of parasites was pretreated with Hoechst to stain the nuclei so that DMSO- and RAP-
treated parasites could be viewed simultaneously in the same imaging chamber. In the top panel, DMSO-treated parasites are Hoechst-
stained, while in the bottom panel, RAP-treated parasites are Hoechst-stained. Schizonts visible in the first frame that rupture over the course
of the video are circled in white. Scale bar, 10mm. The graph on the right shows a quantification of the percentage of DMSO- and RAP-
treated schizonts that egressed in each 30-min video. Data were collected from six videos, with Hoechst-treated samples depicted in blue.
Statistical significance was measured by unpaired t test, where “***” signifies P , 0.0001. (I) Time series of individual stills from GCa:HA:cKO
time-lapse video microscopy in panel G. Images following representative schizonts for each condition (DMSO and RAP) from 8 to 12 min
after compound 2 washout are shown. Note that the PVM around the RAP-treated schizont remains intact throughout the time series,
whereas the DMSO control has completed egress by 12min. Scale bar, 5mm. (J) Western blot analysis monitoring the release of SERA5
(50 kDa) into the culture supernatant of DMSO- and RAP-treated GCa:HA:cKO schizonts, as a measurement of egress over time. Sampling
times are indicated in minutes. Pellet samples were included as loading controls for full-length SERA5 (120 kDa).
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sis in P. falciparum schizonts (31) and thus artificially elevates cGMP levels, resulted in a
significant increase in cGMP levels in the DMSO- but not the RAP-treated samples, con-
firming that GCa-null schizonts are unable to synthesize cGMP (Fig. 3B). Importantly,
we detected no significant differences in cAMP levels between the control and GCa-
null parasites, nor did cAMP levels increase upon zaprinast treatment (Fig. 3C), consist-
ent with our previous findings (31).
Next, we investigated whether Ca21 release from internal stores into the cytosol, a
PKG-dependent process that is essential for merozoite egress (22), was impaired in the
GCa knockout parasites. Treatment with the PDE inhibitor zaprinast specifically indu-
ces PKG-mediated calcium release (22). We measured zaprinast-induced Ca21 release
in DMSO- and RAP-treated GCa:HA:cKO parasites by loading cells with the fluorescent
calcium indicator Fluo-4 AM. As shown in Fig. 3D, while zaprinast treatment stimulated
elevated cytosolic Ca21 levels in control schizonts no such elevation of Ca21 levels was
detected in the GCa-null schizonts (Fig. 3D). Importantly, both control and GCa-null
schizonts showed similar response levels to the calcium ionophore A23187, which
FIG 3 GCa disruption leads to a complete loss of cGMP production and a block in PKG-mediated calcium release. (A)
Representative images of Giemsa-stained schizonts from DMSO-treated GCa:HA:cKO parasites in the presence of
1.5mM compound 2 and RAP-treated GCa:HA:cKO parasites at 50 h postinvasion. PKG inhibition leads to a similar
phenotype to that observed in GCa-null parasites. Scale bar, 5mm. (B) Comparison of intracellular cGMP levels in wild-
type and GCa-null schizonts. Schizonts from DMSO- and RAP-treated GCa:HA:cKO cultures were matured in the
presence of 1.5mM compound 2 to prevent egress. Segmented schizonts were either lysed directly (– zaprinast) or
pretreated with 75mM zaprinast for 3 min prior to cell lysis (1 zaprinast). All samples were lysed in 0.1 M HCl to
inactivate all PDEs, and extracts were analyzed by using a commercial ELISA-based cGMP detection assay. The data
presented are means from four independent experiments, each assayed in duplicate. Error bars indicate the standard
deviations. Statistical significance was measured by unpaired t test (**, P , 0.01; ***, P , 0.001). (C) The samples
described in panel B were assayed in parallel for cAMP with an ELISA-based cAMP kit from the same manufacturer.
The data presented are means from four independent experiments, each performed in duplicate. Error bars indicate
the standard deviations. Statistical significance was measured by unpaired t test (n.s., not significant). (D)
Determination of PKG-mediated calcium release from internal stores in wild-type and GCa KO schizonts. Fluo-4-loaded
mature DMSO- and RAP-treated GCa:HA:cKO schizonts were treated with 75mM zaprinast (left panel) or 20mM
ionophore A23187 (right panel), and the mobilization of Ca21 was measured by fluorimetry. Zaprinast signals (left plot)
were normalized to their respective ionophore control. Ionophore signals were normalized to the DMSO-treated
sample (right plot). Data plotted are mean values from two independent experiments performed in triplicate. Error
bars indicate the standard deviations.
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allows Ca21 ions to cross cell membranes, indicating that internal calcium stores were
not affected in the absence of GCa (Fig. 3D). Together, these results clearly identify
GCa as a functional GC and establish that it generates the cGMP signal in asexual
blood-stage schizonts essential for PKG activation, PKG-dependent Ca21 release, and
ultimately merozoite egress.
Chemical complementation of GCa-null parasites with PET-cGMP rescues the
egress defect. Since the egress phenotype observed in GCa-deficient parasites is most
likely due to their inability to produce cGMP to activate PKG, we reasoned that bypass-
ing the need for cGMP synthesis by directly activating PKG could potentially rescue the
egress defect. We also anticipated that this might reveal a second phenotype resulting
from loss of the ATPase domain. To test this notion, we supplemented cultures con-
taining highly mature RAP-treated cycle 0 GCa:HA:cKO schizonts with either cGMP or
two cGMP analogues, 1-NH2-cGMP and PET-cGMP, both of which have previously been
shown to activate recombinant apicomplexan PKG (37, 38). While cGMP and 1- NH2-
cGMP show similar levels of membrane permeability, PET-cGMP is 50-fold more lipo-
philic (https://www.biolog.de/technical_info_lipophilicity-data) due to its possession of
a b-phenyl-1,N2-ethenoguanosine extension to the purine ring of cGMP. After 1 h of
incubation in the presence of various concentrations of cGMP, 1-NH2-cGMP, or PET-
cGMP, microscopic examination of the cultures revealed that PET-cGMP was highly
effective at rescuing the egress block, resulting in the release of merozoites at all con-
centrations tested (Fig. 4A; see also Fig. S4A). While rings with normal morphology
could be observed in the cultures containing the lower concentrations of PET-cGMP
(15, 31.2, and 62.5mM), the cultures supplemented with higher PET-cGMP concentra-
tions contained numerous intracellular or extracellular pyknotic forms, indicating toxic-
ity (Fig. 4B). Few rings were observed in the cGMP and 1-NH2-cGMP-treated cultures,
indicating limited activity of these compounds (Fig. 4A). It was concluded that PET-
cGMP efficiently reversed the egress defect displayed by the GCa-deficient parasites
(Fig. 4A).
To determine the optimum concentrations of PET-cGMP to sustain replication of
the GCa-null parasites, parasite proliferation was assessed over a 72-h period (1.5
erythrocytic cycles) in the continuous presence of various concentrations of PET-cGMP.
Interestingly, this revealed that none of the concentrations tested could rescue replica-
tion of the GCa-null parasites (Fig. 4C), including those concentrations that efficiently
rescued egress in the short-term assays described above. To try to understand this, we
performed parallel assays assessing growth of control, DMSO-treated GCa:HA:cKO par-
asites in cultures supplemented with the same range of PET-cGMP concentrations. This
revealed that PET-cGMP is toxic, with a half-maximal effective concentration (EC50) of
12.496 0.06mM (Fig. 4C). Given its capacity to rescue the egress defect in GCa-null
parasites, we considered that the toxic effect of prolonged exposure to the compound
is likely explained by premature activation of PKG as the parasites matured, perhaps
resulting in premature egress and release of noninvasive merozoites, a phenomenon
previously observed upon treatment of schizonts with zaprinast (31). Furthermore,
since bioinformatic analysis has revealed that PKG is the only predicted cGMP effector
in Plasmodium parasites, it is unlikely that the toxic effects observed following PET-
cGMP treatment are due to the activation of off-target effectors. In support of this
model, further work showed that mature DMSO- and RAP-treated GCa:HA:cKO schiz-
onts tolerated short-term incubation with 30mM PET-cGMP, followed by washing off
the compound ;10 h later, after the majority of schizonts had ruptured and formed
rings; under these conditions, the new rings successfully matured to form cycle 1 schiz-
onts (see Fig. S4B). Based on these findings, we used flow cytometry to quantify the
degree of rescue that could be achieved over a single egress/invasion cycle.
Quantification of cycle 1 parasite levels the following day showed that the presence of
PET-cGMP during egress and invasion produced a 3.6-fold increase in parasitemia in
the GCa-null cultures, while parallel cultures of GCa-null parasites lacking PET-cGMP
completely failed to expand (Fig. 4D). In contrast, the replication rate of control
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parasites was slightly reduced (from 6.5- to 5-fold) by similar short-term treatment with
PET-cGMP, perhaps indicative of the low levels of toxicity of the compound (Fig. 4D).
These results confirmed the capacity of PET-cGMP to rescue the egress defect in the
GCa-null parasites. Of particular significance, since the conditional strategy used to dis-
rupt the GCa gene was designed to excise key segments of both the cyclase and the
ATPase-encoding sequences, the results indicated either that the ATPase domain has
no essential function or that its function is to stimulate or activate cGMP synthesis,
allowing its role to be bypassed by the presence of the cGMP analogue.
A conserved catalytic Asp residue within the ATPase domain is required for
parasite survival. The N-terminal portion of GCa encodes a putative P-type ATPase
that shares closest homology with type IV ATPases (P4-ATPases) (5) which in other
organisms flip phospholipids from the outer to the inner leaflet of a lipid bilayer (12,
13). P-type ATPases possess 10 transmembrane helices that facilitate transport of
FIG 4 The addition of PET-cGMP efficiently rescues the egress block phenotype of GCa knockout schizonts. (A)
Quantification of the effect of various concentrations of cGMP, 1-NH2-cGMP, and PET-cGMP on the reversal of
the egress block and promotion of ring-stage development in RAP-treated GCa:HA:cKO parasites. Ten
microscopic fields per condition were counted blindly by two researchers, and parasites were scored as either
unruptured (trophozoites and schizonts), uninvaded (free merozoites and pyknotic), or invaded (ring stages).
The data are presented as proportions of the different forms of total parasites counted. Values are means of
counts by each researcher. Error bars indicate the standard deviations. (B) Representative Giemsa images
of pyknotic forms observed in smears taken from RAP-treated GCa:HA:cKO cultures 1 h after the addition of
62.5mM PET-cGMP in the experiment quantified in panel A. (C) Continuous PET-cGMP treatment is toxic and
does not rescue GCa-null parasite growth. Growth of DMSO- and RAP-treated GCa:HA:cKO parasites at
different concentrations of PET-cGMP as measured in a 72-h SYBR green growth assay. Assays were repeated
twice, and the mean EC50 of PET-cGMP was measured as 12.496 0.06mM in wild-type parasites (DMSO). Error
bars indicate the standard deviations. (D) Comparison of replication rates from cycle 0 to cycle 1 of DMSO- and
RAP-treated GCa:HA:cKO parasites cultured in the presence or absence of 30mM PET-cGMP, as measured by
flow cytometry-based counting of SYBR green-positive cells. PET-cGMP was added when mature segmented
schizonts appeared in culture and washed off ;10 h later, once rings had formed. Data points plotted are
means from two repeat experiments, each performed in triplicate. Error bars indicate the standard deviations.
Statistical significance was measured by a ratio paired t test, with “*” signifying P . 0.05 (0.0177). n.s., not
significant.
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ligands according to the Post-Albers mechanism (39). This requires the following cyto-
plasmic components: a nucleotide binding domain (N-domain), which binds ATP; a
phosphorylation domain (P-domain), which contains a highly conserved aspartate
(Asp) residue that becomes autophosphorylated to form an aspartyl phosphate inter-
mediate; and an actuator domain (A-domain), which dephosphorylates the phospho-
rylation domain (40, 41) (Fig. 5A). ATP-dependent autophosphorylation of the con-
served Asp, which lies within a DKTGT motif, leads to a rotational change in the
actuator domain surrounding the phosphorylation site; dephosphorylation is then
coupled to inward transport of phospholipids or ions in the respective P-type ATPase
families. Alignment of the GCa N-terminal region with other P4-ATPases, including
human ATP8A1, for which a crystal structure has recently been determined (12), shows
that of the 56 residues identical in P4-ATPases and P2-ATPases (a Ca21 transporting
SERCA and a Na1-K1P-type ATPase) that are required for ATP binding and catalysis, 47
are also identical in GCa and 2 are similar, fully consistent with the GCa sequence rep-
resenting a functional ATPase domain (see Fig. S5).
Previous functional investigations (reviewed in reference 9) and two recent struc-
tural studies on yeast Drs2p and human ATPase8A1 in complex with their respective
CDC50 partners (12, 13) have demonstrated the importance of the transmembrane
domains of P4-ATPases, particularly TM1 to TM4 (but also TM6), for lipid binding and
translocation. Key among these is the PISL motif in TM4 which is highly conserved in
P4-ATPases and is also present in the GCa sequence. This motif constitutes an
FIG 5 Key functional domains of the ATPase domain of GCa and strategy for substitution of the phosphorylation site aspartate. (A) Cartoon
showing details of the predicted ATPase topology of P. falciparum GCa. (B) Amino acid alignment of the phosphorylation site within the P-
domain of P4-ATPases. The aligned sequences are as follows: GCa (PlasmoDB identifier PF3D7_1138400), human ATP8A1 (Q9Y2Q0-2), human
ATP8B1 (O43520), yeast Drs2p (P39524), yeast Dnf1 (P32660), T. gondii GC (EPT31724), P. falciparum GCb (PlasmoDB identifier PF3D7_1360500),
rabbit SERCA Ca21-ATPase isoform 1a (P04191), and dogfish Na1/K1-ATPase (Q4H132). (C) Schematic representation of the marker-free CRISPR/
Cas9-mediated approach used to introduce synonymous or nonsynonymous mutations into the ATPase domain of GCa in the GCa:HA line.
Arrows with numbers represent the relative position of oligonucleotide primers used for diagnostic PCR. A pool of three Cas9 plasmids
harboring different gRNA cassettes was transfected, along with a linearized plasmid containing synonymous mutations (D756 control) or
mutations resulting in an amino acid change (D756N), flanked by recodonized (rGCa) and endogenous GCa sequences serving as the template
for homology-directed repair. Promoters/59 UTRs and 39 UTRs/terminators are indicated by arrows and lollipops, respectively. (D) Diagnostic PCR
evidencing modification of the GCa locus by integration of the D756 control construct in two independent transfections. The PCR primers used
are indicated on the right, and their respective binding sites are shown in panel C.
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important difference between the phospholipid and cation transporting ATPases and
is crucial for binding and translocation of their respective substrates. P4-ATPases have
a PISL motif whereas the ion transporters have a PEGL motif. GCa has a PISI motif at
this position which contains the crucial IS pair diagnostic of phospholipid binding/
translocation rather than cation binding/translocation (see Fig. S5). The QQ motif at
the C terminus of TM1 contains noncharged polar residues (e.g., Q and N) which in
human ATP8A1 determine selectivity for PS in P4-ATPases. Q and N can hydrogen
bond to the negative charge of the polar head group of PS, whereas the presence of
small nonpolar residues (A and G) in place of the QQ motif preclude hydrogen bonding
to PS and are features of P4-ATPases that translocate PC (12). GCa has a QN pair corre-
sponding to the QQ motif of human ATP8A1, which is compatible with flipping of PS.
To address whether the ATPase domain of GCa is required for blood-stage replica-
tion, we investigated whether parasites could replicate following substitution of the
conserved Asp (D756) in a manner designed to block formation of the aspartyl phos-
phate intermediate and thus ablate any enzymatic activity of the ATPase. To do this,
we employed marker-free CRISPR/Cas9-mediated gene editing to introduce an aspara-
gine (Asn) substitution of GCa D756 (Fig. 5B) (Fig. 5C; see also Fig. S1), since this substi-
tution has been shown to completely ablate the activity of the yeast Drs2p P-Type
ATPase and is expected to cause minimal structural changes to the ATPase (42). In par-
allel control manipulations, we used a similar approach to introduce synonymous
mutations that did not alter the amino acid sequence but that could be differentiated
from the wild-type locus at the nucleotide level. While parasites with a modified locus
appeared in two of two independent transfections in these control cultures by 2 weeks
posttransfection (Fig. 5D), no parasites emerged from three independent D756N trans-
fections performed in parallel (one was performed in parallel with the successful inte-
gration of the loxPint) even following extended culture (6weeks). Our failure to obtain
viable parasites harboring the D756N mutation after three attempts, while readily
obtaining transgenic parasites possessing synonymous mutations of the D756 codon,
strongly suggests that an active ATPase domain is required for parasite survival. These
data, combined with our ability to rescue the GCa-null growth phenotype by chemical
complementation with PET-cGMP, indicate that the ATPase domain acts upstream of
and is required for GC activity and that the ultimate role of the ATPase domain is to
facilitate cGMP synthesis.
DISCUSSION
Although the single GC in the related apicomplexan parasite T. gondii (14–17) and
GCb in P. falciparum (23), P. berghei (24, 25), and P. yoelii (8) have been previously ana-
lyzed by reverse genetics, there have as yet been no functional studies of GCa in the
asexual blood stages of Plasmodium. Here, we have made important advances in
understanding the essentiality and function of this key component of the cGMP signal-
ing pathway.
Epitope tagging of the endogenous P. falciparum GCa locus indicated that the pro-
tein is located in puncta within the confines of individual merozoites within mature
schizonts. We propose that these puncta represent cytoplasmic membranous struc-
tures, consistent with the architecture of the protein which has 22 predicted trans-
membrane helices. It is likely that the GCa topology is orientated such that the twin
GC catalytic domains face the cytosol in order to allow synthesis of cGMP to activate
PKG, the majority of which is cytosolic (43). Our observed localization for P. falciparum
GCa is reminiscent of that recently described for GCa in P. yoelii gametocytes (44). In
contrast, in Toxoplasma (14–17) the single GC has been localized to the plasma mem-
brane, primarily at the apical pole, in extracellular parasites, a localization similar to
that of GCb in P. yoelii ookinetes. Therefore, unlike PyGCb and TgGC, there is no evi-
dence of subcellular partitioning of cGMP generated by PfGCa in asexual blood stages.
Epitope-tagged P. falciparum GCa migrated in Western blots as an ;175-kDa spe-
cies, much smaller than the predicted full-length protein (;500 kDa). A similar
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phenomenon has been observed in P. yoelii, where GCa migrates at ;175 kDa instead
of the predicted full-length;450 kDa (44), as well as in T. gondii, where TgGC predomi-
nantly migrates at ;125 and ;75 kDa, with only small amounts of the ;460-kDa spe-
cies corresponding to full-length protein detected in some studies (14, 15, 17, 18).
Given the evidence suggesting that the Toxoplasma GC needs to be full length to be
functional (15), it seems that the 175-kDa species observed in our study likely repre-
sents an N-terminally truncated proteolytic fragment, most likely resulting from protein
instability during detergent extraction and that full-length P. falciparum GCa protein is
present but below detection limits in our experiments.
Conditional deletion of a large segment of GCa spanning both the GC catalytic do-
main and the ATPase-like domain prevented asexual blood-stage replication, with a
selective block in egress. This finding was in contrast to results generated in a previous
global transposon-based gene knockout study which suggested that GCa was dispen-
sable for blood-stage replication (45). However, that study acknowledged that false
negatives can be obtained using their approach depending upon the position of trans-
poson insertion. In an in vivo global gene knockout study in P. berghei, parasites in
which GCa was disrupted grew slowly and were close to the cutoff for those essential
for blood-stage replication (46), which is more consistent with our findings in P.
falciparum.
We have previously reported that GCa possesses all the conserved amino acid resi-
dues required for catalytic activity (6). However, the ability of GCa to synthesize cGMP
had previously not been demonstrated. The lack of detectable cGMP generation in
GCa-null parasites confirms that it is a functional GC and also indicates that GCb ,
which is expressed only during mosquito stage development, cannot compensate for
the absence of GCa in blood stages. The lack of cGMP synthesis fully explains the
egress phenotype of GCa-null parasites, because activation of PKG by cGMP is known
to be essential for egress (30, 31). PKG activity also induces calcium release from inter-
nal stores in P. falciparum schizonts, which is required for egress. This is concordant
with our finding that GCa-null schizonts did not mobilize calcium in response to cGMP
elevation by the PDE inhibitor zaprinast. Together, these results establish that GCa is
the key regulator upstream of PKG activity in P. falciparum blood stages. Disruption of
the Toxoplasma GC also abolishes the rises in cytosolic Ca21 required for secretion of
micronemal proteins (17) and motility (47, 48). Recent work in Toxoplasma has revealed
a feedback loop between cGMP and cAMP signaling (18). However, unlike in
Toxoplasma, where cAMP signaling is a negative regulator of egress, P. falciparum mer-
ozoite egress is not affected following disruption of either ACb or PKA (49). Inhibition
of soluble guanylyl cyclase activity following phosphorylation by PKG has been
reported in other systems (50), and we have previously identified that PfGCa is phos-
phorylated at two independent sites in a PKG-dependent manner (33), pointing toward
a possible feedback loop whereby activated PKG may regulate GCa. Future work will
be required to determine the significance of these phosphosites.
It has been suggested that the chemical gradient of phospholipids generated by
P4-ATPases is akin to the chemical gradient of ions created by P2-ATPases to mediate
signal transduction (51). To investigate whether the ATPase-like domain in PfGCa is
likely to be a catalytically active ATPase, we attempted to generate parasites possess-
ing a substitution of a highly conserved aspartate (D756) that is autophosphorylated in
functional ATPases. These parasites could not be selected, while those engineered to
reconstitute the wild-type aspartate proliferated normally, providing evidence that the
ATPase domain is catalytically active and serves an essential function. Our finding that
the GCa-null phenotype could be rescued by addition of the membrane-permeable
cGMP analogue PET-cGMP, strongly suggests that the function of the ATPase domain
is upstream of and directly related to cGMP synthesis. Our findings are consistent with
previous studies in Toxoplasma where the ATPase domain was also shown to be critical
for GC function (14, 15, 17). Complementation of GC-null Toxoplasma with a panel of
mutants demonstrated that the ATPase domain is required for trafficking of GC, activity
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and maximal GC function since stimulated micronemal secretion was only partially
reduced in the ATPase D728A mutant, while natural microneme secretion was pre-
vented (15). Although our data suggest that the activity of the ATPase domain of GCa
is an essential upstream regulatory factor for cGMP synthesis, our study does not fur-
ther address its biochemical activity or indeed how it facilitates cGMP synthesis. The
single Toxoplasma GC is involved in sensing phosphatidic acid, as well as changes in
pH and potassium levels, to mediate egress (14, 17). A recent suggestion that P. falcipa-
rum GCa might flip phosphatidylcholine (52) to mediate cGMP-stimulated egress was
not supported by direct evidence of GCa-mediated flipping of phosphatidylcholine.
Our analysis has shown the presence of a QN pair in P. falciparum at the C terminus of
TM1 in GCa, which corresponds to the QQ motif of human ATP8A1 (12), suggesting
that the sequence is compatible with flipping of PS. Future work will be needed to
determine whether regulation of cGMP synthesis by GCa requires flipping or sensing
of phospholipids by the ATPase domain and whether generation of lipid asymmetry
across membranes contributes to activation of cGMP synthesis. This could be achieved
by complementation of our conditional knockout line with various versions of GCa har-
boring the mutations in the ATPase domain.
Synthesis of cGMP by GCa has been linked to the stimulation of gametogenesis by
xanthurenic acid (XA) (20), but it is not clear whether XA stimulates GCa activity
directly or indirectly through other protein mediators. However, a study in P. yoelii has
recently identified a protein called GEP1 that interacts with GCa, showing that both
are required for XA-stimulated gametogenesis (44). Although cGMP synthesis and PKG
activation are required for merozoite egress, the nature of the upstream signal that
activates GCa in Plasmodium blood stages is unknown. Just prior to natural egress in
Toxoplasma, the parasitophorous vacuole is acidified which triggers micronemal secre-
tion (17). A similar mechanism may operate in Plasmodium. Future work will be needed
to determine the events that occur upstream of cGMP signaling in blood stages and to
understand the role of the P4-type ATPase domain in mediating the egress signal.
MATERIALS ANDMETHODS
Small molecules and antibodies. WR99210 was kindly provided by Jacobus Pharmaceuticals
(Plainsborough Township, NJ). The PKG inhibitor compound 2 (4-[7-[(dimethylamino)methyl]-2-(4-fluo-
rphenyl)imidazo[1,2-a]pyridine-3-yl]pyrimidin-2-amine) was synthesized by LifeArc (London, United
Kingdom). Rapamycin, calcium ionophore A23187, the cysteine protease inhibitor E64, and the PDE
inhibitor zaprinast were all purchased from Sigma-Aldrich (St. Louis, MO). The calcium chelator Fluo-
4-AM was purchased from Thermo Fisher Scientific (Waltham, MA). cGMP, PET-cGMP, and 1-NH2-
cGMP were purchased from the Biolog Life Science Institute (Bremen, Germany).
Rat monoclonal anti-HA tag antibody (clone 3F10) was purchased from Roche LifeScience
(Penzberg, Germany) and rabbit anti-human PKG antibody from Enzo Life Sciences (Farmingdale, NY). A
rabbit polyclonal antibody against MSP1-30 (53) as well as a rabbit anti-AMA1 antibody raised against
the ectodomain (54) and rabbit anti-SERA5 (55) were all described previously. A mouse monoclonal anti-
body to plasmepsin V was kindly provided by Daniel Goldberg (Washington University School of
Medicine in St. Louis, MO).
P. falciparum culture and synchronization. P. falciparum asexual blood stages were cultured in
human erythrocytes (National Blood Transfusion Service, London, United Kingdom) and complete me-
dium (CM) consisting of RPMI 1640 medium (Life Technologies, CA) supplemented with 0.5% AlbuMAX
type II (Gibco), 50mM hypoxanthine, and 2mM L-glutamine. Parasite cultures were incubated at 37°C
and gassed with 90% N2, 5% CO2, and 5% O2 according to standard procedures (56). Parasitemias were
routinely monitored by examination of thin blood films fixed with 100% methanol and stained with 10%
Giemsa stain in phosphate buffer (8mM KH2PO4, 6mM Na2HPO4 [pH 7.0]).
Tightly synchronous parasites were obtained by purifying segmented schizonts on a 70% isotonic
Percoll (GE Healthcare, Arlington Heights, IL) cushion and allowing them to invade fresh erythrocytes for
1 to 2 h while shaking. Unruptured schizonts were lysed by treating with 5% D-sorbitol (Sigma) for 10
min (57) to obtain highly pure and synchronous ring-stage cultures.
Induction of DiCre activity was achieved by treating early ring-stage parasites (2 to 10 h postinva-
sion) with 50 nM RAP for 2 to 3 h. Control parasites were treated with an equivalent volume of the vehi-
cle DMSO (0.5% [vol/vol]).
Transfection of P. falciparum schizonts. Highly synchronous late-stage schizonts were used for
transfection as previously described (35) using an Amaxa 4D-Nucleofector system (Lonza, Basel,
Switzerland). For each transfection, ;1.25 108 Percoll-enriched schizonts were resuspended in supple-
mented P3 primary cell solution containing 20 to 50mg of plasmid DNA and transferred to a
Nucleocuvette. Parasites were electroporated using the FP158 setting and then transferred back into
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culture. Modified parasites were selected 24 h posttransfection by addition of WR99210 (2.5 nM).
WR99210 was removed 7 days later when selecting for the presence Cas9/gRNA plasmids (GCa:HA:cKO
and ATPase mutation) or left on until parasites emerged and then cycled on/off WR (GCa:HA).
Plasmid construction. Primers used throughout this study were ordered from Integrated DNA
Technologies (IDT, Coralville, IA) and are listed in Table S1 in the supplemental material. To generate the
GCa:HA parasite line, a 1.9-kb fragment corresponding to the 39 end of the GCa coding region was PCR
amplified with primers 14 and 15 and cloned into pHH1_PreDiCre_A_deltaH_deltaE (35) via EcoRV and
XhoI restriction sites, upstream of the sequence encoding a triple hemagglutinin (3HA) tag. The result-
ing plasmid pHH1_PreDiCre_GCa-3HA was transfected into the 3D7/1G5DiCre line constitutively
expressing dimerizable Cre recombinase (35). Transfected cultures were selected with WR99210 and
then subjected to drug cycling to enrich for parasites having integrated the plasmid via single crossover
recombination. Cultures were finally treated with RAP to activate Cre recombinase to recycle the hdhfr
resistance marker. A clonal GCa:HA line sensitive to WR99210 was selected and further modified by
CRISPR/Cas9-mediated gene editing to introduce a loxPint sequence into the ATPase domain of GCa to
generate the GCa:HA:cKO line. A pUC19-based repair template was generated by first amplifying a 545-
bp 59 homology region and a 627-bp 39 homology region from genomic DNA using the primer pairs 16/
17 and 18/13, respectively. The two PCR products were fused by overlap extension PCR using primers
16/13 and InFusion cloned into the HindIII and EcoRI sites of pUC19. A synthetic recodonized region of
the GCa gene from bp 2109 to bp 2340 containing a SERA2-derived loxPint was ordered as a gBlock
(IDT) and InFusion cloned into the AflII and BamHI sites located between the 59 and 39 homology
regions. The repair template was linearized using PvuI and transfected, along with three pooled pDC2
plasmids, each encoding the Cas9 protein, the hDHFR selection cassette (which confers resistance to
the antifolate WR99210), and a unique sgRNA sequence targeting either TTTAATATGTGTTCTATAGC,
TCTATAGCAGGAAAAACATA, or CATATTCATCATAATCATTT. To mutate the ATPase domain of GCa, the
repair template used to introduce the loxPint was modified to introduce either a D756N mutation,
which would block formation of the aspartyl phosphate intermediate, or a wild-type D756 synony-
mous mutation, which would serve as a control. The repair templates were generated by replacing the
loxPint flanked by the BglII and KpnI sites with overlap extension PCR products from primer sets 19/20
and 21/22 to introduce the D756N and D756 alleles, respectively. Each repair template plasmid was
linearized with PvuI, combined with the pool of three pDC2 Cas9 plasmids mentioned above, and
transfected into wild-type 3D7 parasites.
Limiting dilution to generate clonal parasite lines. Clonal parasite lines were obtained by limiting
dilution combined with a plaque formation readout as previously described (58). The hematocrit and
parasitemia of parasite cultures were determined by using a hemocytometer and by counting Giemsa-
stained thin blood smears. Briefly, parasite cultures were diluted to give 0.3 parasites in 200ml of culture
at 1% hematocrit per well in a 96-well flat-bottom plate. After 9 days, plaque formation was assessed by
using an EVOS FL cell imaging system (Thermo Fisher Scientific). Wells containing single plaques were
subsequently expanded and analyzed by PCR.
Diagnostic PCRs. Integration of the 3HA-tagging construct into the GCa locus was confirmed
using primers 1/2. RAP-induced excision of the hDHFR cassette to create the GCa:HA line was validated
using primers 1/4. Integration of the artificial loxPint into the ATPase domain of the GCa locus to gener-
ate the GC:HA:cKO line was confirmed using primers 5/7, while primers 5/6 were used to detect the pres-
ence of wild-type locus. Cre-mediated excision was validated using the primer pairs 10/11 and 12/11 to
detect the unexcised and excised loci, respectively. Primers 8/9, which amplify a segment in an unmodi-
fied distal locus, served as a DNA quality control.
SYBR green growth inhibition assays. To determine the effect of various test compounds on para-
site growth, their EC50s were determined by using the SYBR green growth inhibition assay adapted from
a previous study (59). Test compounds were added as a series of 2-fold serial dilutions in triplicate to 96-
well flat-bottom plates. Wells containing no drug or 10 nM chloroquine were also included in each plate
and served as negative and positive controls, respectively. Synchronous ring-stage parasites were added
to achieve a starting parasitemia of 2% at 1% hematocrit and incubated at 37°C in a sealed gassed box
for 72 h. Parasites were then lysed in buffer containing 20mM Tris, 5mM EDTA, 0.008% saponin, 0.08%
Triton X-100, and 1 SYBR green I (Molecular Probes, Eugene, OR) at pH 7.5 and incubated for 1 h at
room temperature. SYBR green fluorescence was measured using a SpectraMax M3 plate reader
(Molecular Devices, San Jose, CA) with excitation and emission wavelengths of 485 and 535 nm, respec-
tively. EC50 values were determined by nonlinear regression analysis.
Fluorescence-activated cell sorting analysis to measure parasite growth and DNA content.
Parasite cultures were seeded in triplicate wells per condition and samples were fixed in 4% formalde-
hye, 0.1% glutaraldehyde in PBS containing 1 SYBR green I (Molecular Probes) and stored at 4°C over-
night. The fixative was aspirated, and the cells were washed in PBS and then analyzed using a BD LSR II
flow cytometer (BD Biosciences, Franklin Lakes, NJ), with 50,000 events collected for each sample.
FlowJo 7 analysis software (FlowJo LLC, Ashland, OR) was used to analyze the data.
Immunofluorescence microscopy. Air-dried thin blood smears were fixed in 4% formaldehyde in
phosphate-buffered saline (PBS) for 20 min at room temperature, followed by permeabilization with
0.1% Triton X-100 in PBS. Blocking and antibody binding steps were performed in PBS containing 3% bo-
vine serum albumin. Dual staining experiments were performed sequentially, starting with rat anti-HA,
to eliminate cross-reactivity of the anti-rat secondary antibody with mouse or rabbit IgG. The secondary
antibodies used were anti-rat IgG antibody conjugated to Alexa Fluor 488, anti-rabbit IgG conjugated to
Alexa Fluor 594, and anti-mouse IgG conjugated to Alexa Fluor 594, all highly cross-adsorbed. Slides
were mounted in ProLong Gold Antifade Mountant containing 49,69-diamidino-2-phenylindole (DAPI;
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Thermo Fisher Scientific). Images were acquired at 100 magnification using a Nikon Eclipse Ti fluores-
cence microscope fitted with a Hamamatsu C11440 digital camera and overlaid in ICY bioimage analysis
software (icy.bioimageanalysis.org).
Time-lapse video microscopy. Parasite egress was monitored by differential interference contrast
(DIC) coupled with fluorescence microscopy using a Nikon Eclipse Ti fluorescence microscope with a
60 oil immersion objective and fitted with a Hamamatsu C11440 digital camera. Segmented schizonts
treated with C2 (1.5mM) overnight were Percoll enriched and resuspended in warm complete medium
at 0.4% hematocrit, transferred to prewarmed Poly-L-Lysine m-Slide VI 0.4 (IBIDI, Planegg, Germany)
imaging chambers and imaged on a temperature-controlled microscope stage held at 37°C. To visualize
DMSO- and RAP-treated parasites simultaneously, one culture was stained with 1mg/ml Hoechst 33342
prior to washing off C2 and pooling the cultures, as previously described (60). Images were taken every
5 s for a total of 20 to 30 min, and the resulting videos were processed and analyzed in ICY bioimage
analysis software (icy.bioimageanalysis.org).
Microscopy of Giemsa-stained blood films. Thin blood films fixed with 100% methanol and stained
with 10% Giemsa stain in phosphate buffer (8mM KH2PO4, 6mM Na2HPO4 [pH 7.0]) were imaged using
an Olympus BX51 microscope fitted with an Olympus SC30 digital color camera through a 100 oil
immersion objective. Images were processed in Graphic (Picta, Inc.).
Parasite protein extraction, SDS-PAGE, and immunoblotting. Saponin-released parasites were
lysed in 4 pellet volumes of CoIP buffer (150mM NaCl, 0.5mM EDTA, 1% NP-40, 10mM Tris [pH 7.5]) sup-
plemented with cOmplete EDTA-free protease inhibitor (Roche, Basel, Switzerland). Samples were incu-
bated on ice for 10 min and centrifuged at 12,000 g for 10 min at 4°C, and the supernatant was col-
lected. Reducing SDS sample buffer was added, and proteins were resolved on 4 to 15% Mini-Protean
TGX stain-free precast gels (Bio-Rad, Hercules, CA) or 3 to 8% NuPAGE Tris-acetate protein gels (Thermo
Fisher Scientific) for high-molecular-weight proteins. Proteins were transferred onto nitrocellulose mem-
branes using a semidry Trans-Blot Turbo transfer system (Bio-Rad) and blocked using 10% skimmed milk
in PBS containing 0.1% Tween 20 (PBST). Antibody incubations were carried out in 1% skimmed milk in
PBST and washed in PBST. After incubation with secondary antibodies conjugated to near-infrared dyes,
washed membranes were dried between Whatman 3MM blotting papers and imaged using an Azure
c600 imaging system (Azure Biosystems, Dublin, CA) or a ChemiDoc imaging system (Bio-Rad).
Egress assays. Highly synchronous mature segmented schizonts from DMSO- and RAP-treated GCa:
HA:cKO cultures that were treated with C2 (1.5mM) at the early trophozoite stage were enriched on a
Percoll gradient and washed several times in prewarmed RPMI. Parasites were resuspended in RPMI at
3.25 108 parasites/ml, and 65-ml aliquots were dispensed into Eppendorf tubes. To harvest samples at
each time point, parasites were pelleted at 9,000 g, and culture supernatants were purified using 0.22-
mm Costar Spin-X centrifuge filters (Corning, Corning, NY). The parasite pellets from the first time point
were retained as a parasite loading control. Samples were subjected to Western blot analysis and probed
for SERA5 as a measure of merozoite egress.
Calcium release assays. Mature segmented schizonts from RAP- and DMSO-treated cultures were
Percoll enriched, and ;1.25 108 cells from each condition were incubated in phenol red-free RPMI
containing 10mM Fluo-4-AM (Invitrogen, Carlsbad, CA) in the dark at 37°C for 45 min. The parasites were
washed twice in prewarmed phenol red-free RPMI and then incubated for 20 min to allow for de-esterifi-
cation of the AM ester. The parasites were washed twice and resuspended in phenol red-free RPMI at
1.25 108 parasites/ml. Next, 100ml of resuspended parasites was added again to wells on the bottom
half of a 96-well plate. Three wells containing phenol red-free RPMI were also included as a control.
Baseline Fluo-4 fluorescence in each well was read at 22-s intervals for 3 min using a SpectraMax M3
plate reader (Molecular Devices) prewarmed to 37°C with excitation and emission wavelengths of 483
and 525 nm, respectively. The plate was removed from the reader onto a heat block prewarmed to 37°C,
and the parasites were resuspended and transferred to wells containing test compounds to give the
desired final concentrations of zaprinast (75mM), ionophore A23187 (20mM), and DMSO (1.5%). The
plate was placed back in the reader and read for a further 5 min at 22-s intervals. All samples were run in
triplicate. The relative fluorescence units from reads at each time point and condition were averaged,
and baseline and DMSO control values were subtracted.
Measurement of intracellular cyclic nucleotide levels. Intracellular cyclic nucleotide levels in
mature segmented schizonts were measured using enzyme-linked immunosorbent assay (ELISA)-based
high-sensitivity direct cAMP and cGMP colorimetric assay kits (Enzo Life Sciences). Around 1.25 108
Percoll-purified schizonts were obtained from RAP- and DMSO-treated cultures to which C2 (1.5mM)
had been added to prevent schizont rupture. The purified schizonts were incubated for 3 min in RPMI
containing C2 only or C2 in the presence of the PDE inhibitor zaprinast (75mM). Parasites were then pel-
leted at 9,000 g, resuspended in 100ml of 0.1 M HCl, and incubated for 10 min at room temperature
with intermittent vortexing to complete cell lysis. The samples were pelleted at 9,000 g, and the super-
natant was collected and stored at –80°C until required. Once all biological replicates were collected,
each sample was diluted by adding 400ml of 0.1 M HCl. Samples and standards were acetylated in order
to improve sensitivity according to the manufacturer’s instructions.
The detection ranges were 0.078 to 20 pmol/ml and 0.08 to 50 pmol/ml for the cAMP and cGMP
assays, respectively. All samples and standards were set up in duplicate. Absorbance was measured at
405 nm using a SpectraMax M3 plate reader (Molecular Devices).
Treatment of parasite cultures with cGMP analogues to rescue GCa KO phenotype. Highly syn-
chronous mature segmented schizonts from RAP-treated cultures at ;48 h postinvasion were treated
with cGMP, 1-NH2-cGMP, or PET-cGMP at concentrations ranging from 15.6 to 250mM. Giemsa-stained
thin blood smears were taken after 2 h, and parasites were scored for their viability based on
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morphology. Parasites in 10 microscopic fields per condition were assigned to schizont, merozoite/
pyknotic intracellular, or ring-stage categories. Counts were performed blindly by two researchers. To
measure the effect of 30mM PET cGMP on wild-type and GCa KO replication rates, the cGMP analogue
was added to synchronous DMSO- and RAP-treated GCa:HA:cKO cultures when segmented schizonts
appeared and washed off 10 h later; the parasites were then harvested for fluorescence-activated cell
sorting (FACS) analysis at the ensuing early schizont stage.
Sequence alignments. Sequence alignments were performed using Clustal Omega, modified man-
ually, and guided by the alignment presented in a recent P4-ATPase structural study (12).
Data analysis and statistical significance tests. GraphPad Prism 7 was used for all statistical analy-
ses. The numbers of biological and technical replicates for each experiment are noted in the figure
legends.
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